Archives of Clinical Infectious Diseases

Published by: Kowsar

Extended-Spectrum Beta-Lactamases Producing Pseudomonas aeruginosa Isolated From Patients With Ventilator Associated Nosocomial Infection

Mohammad Sadegh Rezai 1 , Fatemeh Ahangarkani 2 , Alireza Rafiei 3 , Azin Hajalibeig 1 and Masoumeh Bagheri-Nesami 1 , *
Authors Information
1 Pediatric Infectious Diseases Research Center, Mazandaran University of Medical Sciences, Sari, Iran
2 Student Research Committee, Antimicrobial Resistance Research Center, Mazandaran University of Medical Sciences, Sari, Iran
3 Department of Immunology, Molecular and Cell Biology Research Center, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran
Article information
  • Archives of Clinical Infectious Diseases: August 2018, 13 (4); e13974
  • Published Online: August 5, 2018
  • Article Type: Research Article
  • Received: May 23, 2017
  • Revised: November 8, 2017
  • Accepted: December 10, 2017
  • DOI: 10.5812/archcid.13974

To Cite: Rezai M S, Ahangarkani F, Rafiei A, Hajalibeig A, Bagheri-Nesami M. Extended-Spectrum Beta-Lactamases Producing Pseudomonas aeruginosa Isolated From Patients With Ventilator Associated Nosocomial Infection, Arch Clin Infect Dis. 2018 ; 13(4):e13974. doi: 10.5812/archcid.13974.

Copyright © 2018, Archives of Clinical Infectious Diseases. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Custovic A, Smajlovic J, Hadzic S, Ahmetagic S, Tihic N, Hadzagic H. Epidemiological surveillance of bacterial nosocomial infections in the surgical intensive care unit. Mater Sociomed. 2014;26(1):7-11. doi: 10.5455/msm.2014.26.7-11. [PubMed: 24757393]. [PubMed Central: PMC3990379].
  • 2. Trouillet JL, Vuagnat A, Combes A, Kassis N, Chastre J, Gibert C. Pseudomonas aeruginosa ventilator-associated pneumonia: comparison of episodes due to piperacillin-resistant versus piperacillin-susceptible organisms. Clin Infect Dis. 2002;34(8):1047-54. doi: 10.1086/339488. [PubMed: 11914992].
  • 3. Boyer A, Doussau A, Thiébault R, Venier AG, Tran V, Boulestreau H, et al. Pseudomonas aeruginosa acquisition on an intensive care unit: relationship between antibiotic selective pressure and patients' environment. Crit Care. 2011;15(1):R55.
  • 4. Trautmann M, Lepper PM, Haller M. Ecology of Pseudomonas aeruginosa in the intensive care unit and the evolving role of water outlets as a reservoir of the organism. Am J Infect Control. 2005;33(5):S41-9.
  • 5. Krishnamurthy V, Vijaykumar GS, Sudeepa Kumar M, Prashanth HV, Prakash R, Nagaraj ER. Phenotypic and Genotypic Methods for Detection of Extended Spectrum β Lactamase Producing Escherichia coli and Klebsiella pneumoniae Isolated from Ventilator Associated Pneumonia. J Clin Diagn Res. 2013;7(9):1975-8. doi: 10.7860/jcdr/2013/6544.3376.
  • 6. Koenig SM, Truwit JD. Ventilator-associated pneumonia: diagnosis, treatment, and prevention. Clin Microbiol Rev. 2006;19(4):637-57. doi: 10.1128/CMR.00051-05. [PubMed: 17041138]. [PubMed Central: PMC1592694].
  • 7. Fahimzad A, Eydian Z, Karimi A, Shiva F, Sayyahfar S, Kahbazi M, et al. Surveillance of Antibiotic Consumption Point Prevalence Survey 2014: Antimicrobial Prescribing in Pediatrics Wards of 16 Iranian Hospitals. Arch Iran med. 2016;19(3):204-9.
  • 8. Bayani M, Siadati S, Rajabnia R, Taher AA. Drug resistance of Pseudomonas aeruginosa and Enterobacter cloacae isolated from ICU, Babol, Northern Iran. Int J Mol Cellular Med. 2013;2(4):204.
  • 9. Rezai MS, Pourmousa R, Dadashzadeh R, Ahangarkani F. Multidrug resistance pattern of bacterial agents isolated from patient with chronic sinusitis. Caspian J Int Med. 2016;7(2):114.
  • 10. Bagheri-Nesami M, Rafiei A, Eslami G, Ahangarkani F, Rezai MS, Nikkhah A, et al. Assessment of extended-spectrum β-lactamases and integrons among Enterobacteriaceae in device-associated infections: multicenter study in north of Iran. Antimicrobial Resis Infect Control. 2016;5(1):52.
  • 11. Subashini J, Kannabiran K. Screening and Identification of Extended Spectrum β-lactamase (ESBL) Pathogens in Urine Sample of UTI Patient?s. Trop Med Surg. 2013;1(3). doi: 10.4172/2329-9088.1000120.
  • 12. Nordmann P, Dortet L, Poirel L. Rapid Detection of Extended-Spectrum- -Lactamase-Producing Enterobacteriaceae. J Clin Microbiol. 2012;50(9):3016-22. doi: 10.1128/jcm.00859-12.
  • 13. Poirel L, Le Thomas I, Naas T, Karim A, Nordmann P. Biochemical Sequence Analyses of GES-1, a Novel Class A Extended-Spectrum beta -Lactamase, and the Class 1 Integron In52 from Klebsiella pneumoniae. Antimicrob Agents Ch. 2000;44(3):622-32. doi: 10.1128/aac.44.3.622-632.2000.
  • 14. Ardalan N, Jamaran S, Memari F, Davari K, Rostami B, Ramazanzadeh R. Risk Factors Associated with Community-acquired CTX-M Producing Klebsiella pneumoniae Typing by Rep-PCR in Sanandaj, Iran. Biosci Biotech Res Asia. 2016;13(3):1311-7. doi: 10.13005/bbra/2271.
  • 15. Marquez C, Labbate M, Ingold AJ, Roy Chowdhury P, Ramirez MS, Centron D, et al. Recovery of a functional class 2 integron from an Escherichia coli strain mediating a urinary tract infection. Antimicrob Agents Chemother. 2008;52(11):4153-4. doi: 10.1128/AAC.00710-08. [PubMed: 18794381]. [PubMed Central: PMC2573131].
  • 16. Lavakhamseh H, Mohajeri P, Rouhi S, Shakib P, Ramazanzadeh R, Rasani A, et al. Multidrug-Resistant Escherichia coli Strains Isolated from Patients Are Associated with Class 1 and 2 Integrons. Chemotherapy. 2016;61(2):72-6. doi: 10.1159/000438666. [PubMed: 26562504].
  • 17. Azizi O, Shakibaie MR, Badmasti F, Modarresi F, Ramazanzadeh R, Mansouri S, et al. Class 1 integrons in non-clonal multidrug-resistant Acinetobacter baumannii from Iran, description of the new blaIMP-55 allele in In1243. J Med Microbiol. 2016;65(9):928-36. doi: 10.1099/jmm.0.000315. [PubMed: 27430533].
  • 18. Coque TM, Baquero F, Canton R. Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe. Euro Surveill. 2008;13(47). [PubMed: 19021958].
  • 19. Falagas ME, Karageorgopoulos DE. Extended-spectrum beta-lactamase-producing organisms. J Hosp Infect. 2009;73(4):345-54. doi: 10.1016/j.jhin.2009.02.021. [PubMed: 19596491].
  • 20. Reinert RR, Low DE, Rossi F, Zhang X, Wattal C, Dowzicky MJ. Antimicrobial susceptibility among organisms from the Asia/Pacific Rim, Europe and Latin and North America collected as part of TEST and the in vitro activity of tigecycline. J Antimicrob Chemother. 2007;60(5):1018-29. doi: 10.1093/jac/dkm310. [PubMed: 17855724].
  • 21. Villegas MV, Kattan JN, Quinteros MG, Casellas JM. Prevalence of extended-spectrum β-lactamases in South America. Clin Microbiol Infect. 2008;14:154-8.
  • 22. Behzadnia S, Davoudi A, Rezai MS, Ahangarkani F. Nosocomial infections in pediatric population and antibiotic resistance of the causative organisms in north of iran. Iran Red Crescent Med J. 2014;16(2).
  • 23. Rezai MS, Salehifar E, Rafiei A, Langaee T, Rafati M, Shafahi K, et al. Characterization of multidrug resistant extended-spectrum beta-lactamase-producing Escherichia coli among uropathogens of pediatrics in North of Iran. Bio Med Res Int. 2015;2015.
  • 24. Bagheri-Nesami M, Rezai MS, Ahangarkani F, Rafiei A, Nikkhah A, Eslami G, et al. Multidrug and co-resistance patterns of non-fermenting Gram-negative bacilli involved in ventilator-associated pneumonia carrying class 1 integron in the North of Iran. Germs. 2017;7(3):123.
  • 25. Davoudi A, Najafi N, Alian S, Tayebi A, Ahangarkani F, Rouhi S, et al. Resistance pattern of antibiotics in patient underwent open heart surgery with nosocomial infection in North of Iran. Global J Health Sci. 2016;8(2):288.
  • 26. Davoudi AR, Najafi N, Shirazi MH, Ahangarkani F. Frequency of bacterial agents isolated from patients with nosocomial infection in teaching hospitals of Mazandaran University of Medical Sciences in 2012. Caspian J Intern Med. 2014;5(4):227. [PubMed: 25489435]. [PubMed Central: PMC4247487].
  • 27. Saffar MJ, Enayti AA, Abdolla IA, Razai MS, Saffar H. Antibacterial susceptibility of uropathogens in 3 hospitals, Sari, Islamic Republic of Iran, 2002-2003. E Mediterr Health J. 2008;14(3).
  • 28. Rezai MS, Bagheri-nesami M, Hajalibeig A, Ahangarkani F. [Multidrug and cross-resistance pattern of ESBL-producing enterobacteriaceae agents of nosocomial infections in intensive care units]. J Mazandaran U Med Sci. 2017;26(144):39-49. Persain.
  • 29. Rezai MS, Rafiei A, Ahangarkani F, Bagheri-Nesami M, Nikkhah A, Shafahi K, et al. Emergence of extensively drug resistant acinetobacter baumannii-encoding integrons and extended-spectrum beta-lactamase genes isolated from ventilator-associated pneumonia patients. Jundishapur J Microbiol. 2017;10(7).
  • 30. Peymani A, Naserpour-Farivar T, Zare E, Azarhoosh KH. Distribution of blaTEM, blaSHV, and blaCTX-M genes among ESBL-producing P. aeruginosa isolated from Qazvin and Tehran hospitals, Iran. J Prev Med Hyg. 2017;58(2):E155-60. [PubMed: 28900355]. [PubMed Central: PMC5584084].
  • 31. Alikhani MY, Karimi Tabar Z, Mihani F, Kalantar E, Karami P, Sadeghi M, et al. Antimicrobial resistance patterns and prevalence of blaPER-1 and blaVEB-1 genes among ESBL-producing Pseudomonas aeruginosa isolates in West of Iran. Jundishapur J Microbiol. 2014;7(1). doi: 10.5812/jjm.8888. [PubMed: 25147662]. [PubMed Central: PMC4138671].
  • 32. Sedighi M, Halajzadeh M, Ramazanzadeh R, Amirmozafari N, Heidary M, Pirouzi S. Molecular detection of beta-lactamase and integron genes in clinical strains of Klebsiella pneumoniae by multiplex polymerase chain reaction. Rev Soc Bras Med Trop. 2017;50(3):321-8. doi: 10.1590/0037-8682-0001-2017. [PubMed: 28700049].
  • 33. Koneman EW, Allen SD, Janda WM, Schreckenberger R, Winn W. Introduction to microbiology, part II: guidelines for the collection, transport, processing, analysis and reporting of cultures from specific specimen sources. Color Atlas and Textbook of Diagnostic Microbiology, 5th ed. Lippincot-Raven: Philadelphia. 1997:121-70.
  • 34. Ramazanzadeh R, Rouhi S, Hosainzadegan H, Shakib P, Nouri B. Co-occurrence of Extended-Spectrum Beta-Lactamases in Isolated Enterobacter spp. From Patients Specimens. Arch Clin Infect Dis. 2016;11(3). doi: 10.5812/archcid.26837.
  • 35. Sidjabat HE, Paterson DL, Adams-Haduch JM, Ewan L, Pasculle AW, Muto CA, et al. Molecular epidemiology of CTX-M-producing Escherichia coli isolates at a tertiary medical center in western Pennsylvania. Antimicrob Agents Chemother. 2009;53(11):4733-9. doi: 10.1128/AAC.00533-09. [PubMed: 19687234]. [PubMed Central: PMC2772316].
  • 36. Naas T, Bogaerts P, Bauraing C, Degheldre Y, Glupczynski Y, Nordmann P. Emergence of PER and VEB extended-spectrum beta-lactamases in Acinetobacter baumannii in Belgium. J Antimicrob Chemother. 2006;58(1):178-82. doi: 10.1093/jac/dkl178. [PubMed: 16670107].
  • 37. Kiratisin P, Apisarnthanarak A, Laesripa C, Saifon P. Molecular characterization and epidemiology of extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates causing health care-associated infection in Thailand, where the CTX-M family is endemic. Antimicrob Agents Chemother. 2008;52(8):2818-24. doi: 10.1128/AAC.00171-08. [PubMed: 18505851]. [PubMed Central: PMC2493136].
  • 38. Weldhagen GF, Poirel L, Nordmann P. Ambler class A extended-spectrum beta-lactamases in Pseudomonas aeruginosa: novel developments and clinical impact. Antimicrob Agents Chemother. 2003;47(8):2385-92. [PubMed: 12878494]. [PubMed Central: PMC166056].
  • 39. Chen CH, Huang CC. Risk factor analysis for extended-spectrum β-lactamase-producing Enterobacter cloacaebloodstream infections in central Taiwan. BMC Infect Diseas. 2013;13(1). doi: 10.1186/1471-2334-13-417.
  • 40. Correa FE, Dantas FG, Grisolia AB, Crispim Bdo A, Oliveira KM. Identification of class 1 and 2 integrons from clinical and environmental Salmonella isolates. J Infect Dev Ctries. 2014;8(12):1518-24. doi: 10.3855/jidc.4734. [PubMed: 25500649].
  • 41. Kalanuria AA, Ziai W, Mirski M. Ventilator-associated pneumonia in the ICU. Crit Care. 2014;18(2):208. doi: 10.1186/cc13775. [PubMed: 25029020]. [PubMed Central: PMC4056625].
  • 42. American Thoracic S, Infectious Diseases Society of A. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171(4):388-416. doi: 10.1164/rccm.200405-644ST. [PubMed: 15699079].
  • 43. Vincent JL, Bihari DJ, Suter PM, Bruining HA, White J, Nicolas-Chanoin MH, et al. The Prevalence of Nosocomial Infection in Intensive Care Units in Europe. Jama. 1995;274(8):639. doi: 10.1001/jama.1995.03530080055041.
  • 44. Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med. 2002;165(7):867-903. doi: 10.1164/ajrccm.165.7.2105078. [PubMed: 11934711].
  • 45. Gupta R, Malik A, Rizvi M, Ahmed SM. Incidence of Multidrug-Resistant Pseudomonas Spp. in ICU Patients with Special Reference to ESBL, AMPC, MBL and Biofilm Production. J Glob Infect Dis. 2016;8(1):25-31. doi: 10.4103/0974-777X.176142. [PubMed: 27013841]. [PubMed Central: PMC4785753].
  • 46. Planquette B, Timsit JF, Misset BY, Schwebel C, Azoulay E, Adrie C, et al. Pseudomonas aeruginosa ventilator-associated pneumonia. predictive factors of treatment failure. Am J Respir Crit Care Med. 2013;188(1):69-76. doi: 10.1164/rccm.201210-1897OC. [PubMed: 23641973].
  • 47. Christaki E. Host immune response in sepsis due to ventilator-associated pneumonia: how is it different? Crit Care. 2009;13(6):1009. doi: 10.1186/cc8174. [PubMed: 20017893]. [PubMed Central: PMC2811897].
  • 48. Pelekanou A, Tsangaris I, Kotsaki A, Karagianni V, Giamarellou H, Armaganidis A, et al. Decrease of CD4-lymphocytes and apoptosis of CD14-monocytes are characteristic alterations in sepsis caused by ventilator-associated pneumonia: results from an observational study. Crit Care. 2009;13(6):R172. doi: 10.1186/cc8148. [PubMed: 19883512]. [PubMed Central: PMC2811921].
  • 49. Bouza E, Garcia-Garrote F, Cercenado E, Marin M, Diaz MS. Pseudomonas aeruginosa: a survey of resistance in 136 hospitals in Spain. The Spanish Pseudomonas aeruginosa Study Group. Antimicrob Agents Chemother. 1999;43(4):981-2. [PubMed: 10103217]. [PubMed Central: PMC89243].
  • 50. Niitsuma K, Saitoh M, Kojimabara M, Kashiwabara N, Aoki T, Tomizawa M, et al. [Antimicrobial susceptibility of Pseudomonas aeruginosa isolated in Fukushima Prefecture]. Jpn J Antibiot. 2001;54(2):79-87. [PubMed: 11338681].
  • 51. Shawar RM, MacLeod DL, Garber RL, Burns JL, Stapp JR, Clausen CR, et al. Activities of tobramycin and six other antibiotics against Pseudomonas aeruginosa isolates from patients with cystic fibrosis. Antimicrob Agents Chemother. 1999;43(12):2877-80. [PubMed: 10582875]. [PubMed Central: PMC89580].
  • 52. Chen Z, Niu H, Chen G, Li M, Li M, Zhou Y. Prevalence of ESBLs-producing Pseudomonas aeruginosa isolates from different wards in a Chinese teaching hospital. Int J Clin Exp Med. 2015;8(10):19400-5. [PubMed: 26770582]. [PubMed Central: PMC4694482].
  • 53. Maurya AP, Talukdar AD, Chanda DD, Chakravarty A, Bhattacharjee A. Integron-borne transmission of VEB-1 extended-spectrum beta-lactamase in Pseudomonas aeruginosa in a tertiary care hospital in India. Antimicrob Agents Chemother. 2014;58(11):6966-9. doi: 10.1128/AAC.02365-14. [PubMed: 25182643]. [PubMed Central: PMC4249423].
  • 54. Davodian E, Sadeghifard N, Ghasemian A, Noorbakhsh S. Presence of blaPER-1 and blaVEB-1 beta-lactamase genes among isolates of Pseudomonas aeruginosa from South West of Iran. J Epidemiol Glob Health. 2016;6(3):211-3. doi: 10.1016/j.jegh.2016.02.002. [PubMed: 26944896].
  • 55. Imani Foolad A, Rostami Z, Shapouri R. [Antimicrobial resistance and ESBL prevalence in Pseudomonas aeruginosa strains isolated from clinical specimen by phenotypic and genotypic methods]. J Ardabil U Med Sci. 2010;10(3):189-98. Persain.
  • 56. Bokaeian M, Shahraki Zahedani S, Soltanian Bajgiran M, Ansari Moghaddam A. Frequency of PER, VEB, SHV, TEM and CTX-M Genes in Resistant Strains of Pseudomonas aeruginosa Producing Extended Spectrum beta-Lactamases. Jundishapur J Microbiol. 2015;8(1). e13783. doi: 10.5812/jjm.13783. [PubMed: 25789123]. [PubMed Central: PMC4350043].
  • 57. Jabalameli F, Mirsalehian A, Sotoudeh N, Jabalameli L, Aligholi M, Khoramian B, et al. Multiple-locus variable number of tandem repeats (VNTR) fingerprinting (MLVF) and antibacterial resistance profiles of extended spectrum beta lactamase (ESBL) producing Pseudomonas aeruginosa among burnt patients in Tehran. Burns. 2011;37(7):1202-7. doi: 10.1016/j.burns.2011.05.012. [PubMed: 21703769].
  • 58. Kalantar-Neyestanaki D, Emaneini M, Jabalameli F, Taherikalani M, Mirsalehian A. ISPpu22, a novel insertion sequence in the oprD porin gene of a carbapenem-resistant Pseudomonas aeruginosa isolate from a burn patient in Tehran, Iran. Iran J Microbiol. 2015;7(5):247-50. [PubMed: 26719780]. [PubMed Central: PMC4695505].
  • 59. Pakbaten Toupkanlou S, Najar Peerayeh S, Pirhajati Mahabadi R. Class A and D extended-spectrum β-lactamases in imipenem resistant Pseudomonas aeruginosa isolated from burn patients in Iran. Jundishapur J Microbiol. 2015;8(8). doi: 10.5812/jjm.18352v2. [PubMed: 26468357]. [PubMed Central: PMC4600860].
  • 60. Stokes HW, O'Gorman DB, Recchia GD, Parsekhian M, Hall RM. Structure and function of 59-base element recombination sites associated with mobile gene cassettes. Mol Microbiol. 1997;26(4):731-45. [PubMed: 9427403].
  • 61. Chen J, Su Z, Liu Y, Wang S, Dai X, Li Y, et al. Identification and characterization of class 1 integrons among Pseudomonas aeruginosa isolates from patients in Zhenjiang, China. Int J Infect Dis. 2009;13(6):717-21. doi: 10.1016/j.ijid.2008.11.014. [PubMed: 19208492].
  • 62. Fonseca EL, Vieira VV, Cipriano R, Vicente AC. Class 1 integrons in Pseudomonas aeruginosa isolates from clinical settings in Amazon region, Brazil. FEMS Immunol Med Microbiol. 2005;44(3):303-9. doi: 10.1016/j.femsim.2005.01.004. [PubMed: 15907453].
  • 63. Nikokar I, Tishayar A, Flakiyan Z, Alijani K, Rehana-Banisaeed S, Hossinpour M, et al. Antibiotic resistance and frequency of class 1 integrons among Pseudomonas aeruginosa, isolated from burn patients in Guilan, Iran. Iran J Microbiol. 2013;5(1):36-41. [PubMed: 23466812]. [PubMed Central: PMC3577559].
  • 64. Rajabnia R, Asgharpour F, Ferdosi Shahandashti E, Khalilian M, Norkhomami S, shafii M, et al. Class 1 Integron in Pseudomonas aeruginosa Isolates From Different Places and Devices of ICU in Babol, Iran. Jundishapur J Microbiol. 2013;6(2). doi: 10.5812/jjm.4850.
  • 65. Ahmed OI, El-Hady SA, Ahmed TM, Ahmed IZ. Detection of bla SHV and bla CTX-M genes in ESBL producing Klebsiella pneumoniae isolated from Egyptian patients with suspected nosocomial infections. Egypt J Med Hum Genet. 2013;14(3):277-83. doi: 10.1016/j.ejmhg.2013.05.002.

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments